AI-generated summary
This retrospective study of 30 patients with symptomatic Meibomian gland dysfunction examined combined intense pulsed light and low-level light therapy. The authors report that Ocular Surface Disease Index scores improved at one month and remained better than baseline at one year, with meibography and Oxford scores also improving, while other secondary measures showed no significant change.
- Participants
- 30
- Who or what was studied
- Patients with symptomatic Meibomian gland dysfunction and dry eye symptoms not relieved by medical therapy
- Limits stated in the abstract
- The study is retrospective, with a small sample of 30 patients and no control group stated in the abstract.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Dry eye, GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.